Anti-GPR89A monoclonal antibody

Pre-made anti-GPR89A monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to GPR89A/GPR89A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0941-Ab-1/ GM-Tg-hg-IP0941-Ab-2Anti-Human GPR89A monoclonal antibodyHuman
GM-Tg-rg-IP0941-Ab-1/ GM-Tg-rg-IP0941-Ab-2Anti-Rat GPR89A monoclonal antibodyRat
GM-Tg-mg-IP0941-Ab-1/ GM-Tg-mg-IP0941-Ab-2Anti-Mouse GPR89A monoclonal antibodyMouse
GM-Tg-cynog-IP0941-Ab-1/ GM-Tg-cynog-IP0941-Ab-2Anti-Cynomolgus/ Rhesus macaque GPR89A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0941-Ab-1/ GM-Tg-felg-IP0941-Ab-2Anti-Feline GPR89A monoclonal antibodyFeline
GM-Tg-cang-IP0941-Ab-1/ GM-Tg-cang-IP0941-Ab-2Anti-Canine GPR89A monoclonal antibodyCanine
GM-Tg-bovg-IP0941-Ab-1/ GM-Tg-bovg-IP0941-Ab-2Anti-Bovine GPR89A monoclonal antibodyBovine
GM-Tg-equg-IP0941-Ab-1/ GM-Tg-equg-IP0941-Ab-2Anti-Equine GPR89A monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0941-Ab-1/ GM-Tg-hg-IP0941-Ab-2; GM-Tg-rg-IP0941-Ab-1/ GM-Tg-rg-IP0941-Ab-2;
GM-Tg-mg-IP0941-Ab-1/ GM-Tg-mg-IP0941-Ab-2; GM-Tg-cynog-IP0941-Ab-1/ GM-Tg-cynog-IP0941-Ab-2;
GM-Tg-felg-IP0941-Ab-1/ GM-Tg-felg-IP0941-Ab-2; GM-Tg-cang-IP0941-Ab-1/ GM-Tg-cang-IP0941-Ab-2;
GM-Tg-bovg-IP0941-Ab-1/ GM-Tg-bovg-IP0941-Ab-2; GM-Tg-equg-IP0941-Ab-1/ GM-Tg-equg-IP0941-Ab-2
Products NameAnti-GPR89A monoclonal antibody
Formatmab
Target NameGPR89A
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-GPR89A monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0941-Ag-1Recombinant multi-species GPHRA/ GPR89A/ GPHR protein


    Target information

    Target IDGM-IP0941
    Target NameGPR89A
    Gene ID653519,67549,696579,483157,101096405,767859
    Gene Symbol and Synonyms4933412D19Rik,GPHR,GPR89,GPR89A,GPR89B,SH120,UNQ192
    Uniprot AccessionB7ZAQ6,Q5BIM9
    Uniprot Entry NameGPHRA_HUMAN,GPHR_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000117262
    Target ClassificationIon Channel

    The target: GPR89A, gene name: GPR89A, also named as GPHR, GPR89, GPR89B, SH120, UNQ192. GPR89A is a nearly identical copy of the GPR89B gene (MIM 612806).[supplied by OMIM, Jun 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.